Trial Profile
Impact of single-dose nilotinib on the pharmacokinetic and pharmacodynamic profiles of single-dose warfarin in fed volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 May 2011
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary) ; Warfarin
- Indications Cancer; Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Novartis; Parexel International
- 03 May 2011 New trial record
- 01 Mar 2011 Results published in Clinical Drug Investigation.